Padcev: A New Hope For Patients With Metastatic Urothelial Cancer

In the field of cancer treatment, targeted therapies and antibody-drug conjugates (ADCs) are emerging as breakthrough treatment options. As one of the most important advances in this area, Padcev (generic name: Enfortumab Vedotin) has recently…
